Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 21

Trial Status

Completed1

Role Distribution

Principal Investigator1
PI Rate100%

Activity Timeline

Clinical Trials (1)

NCT00329641Phase 2Completed
Sorafenib, Carboplatin, and Paclitaxel in Treating Patients With Stage IV Melanoma of the Eye
Ciliary Body and Choroid Melanoma, Medium/Large SizeExtraocular Extension MelanomaIris Melanoma+2 more
Principalinvestigator

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Michael McNamara, MD

Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center

Moderately Similar
1 trials

Shared therapeutic areas:

Ciliary Body and Choroid Melanoma, Medium/Large SizeExtraocular Extension MelanomaIris Melanoma+2 more

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score30%

Jeffrey Weber

University of Southern California

Moderately Similar
4 trials

Shared therapeutic areas:

Ciliary Body and Choroid Melanoma, Medium/Large SizeExtraocular Extension MelanomaIris Melanoma+2 more

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score30%

Naomi Balzer-Haas

Princess Margaret Hospital Phase 2 Consortium

Related
1 trials

Shared therapeutic areas:

Ciliary Body and Choroid Melanoma, Medium/Large SizeExtraocular Extension MelanomaIris Melanoma+1 more

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score24%

Sapna Patel

M.D. Anderson Cancer Center

Related
2 trials

Shared therapeutic areas:

Ciliary Body and Choroid Melanoma, Medium/Large SizeIris MelanomaMetastatic Intraocular Melanoma+1 more

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score24%

Gary Croghan

Mayo Clinic

Related
1 trials

Shared therapeutic areas:

Ciliary Body and Choroid Melanoma, Medium/Large SizeExtraocular Extension MelanomaIris Melanoma+1 more

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score24%

Yogen Saunthararajah, MD

Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center

Related
1 trials

Shared therapeutic areas:

Ciliary Body and Choroid Melanoma, Medium/Large SizeIris MelanomaRecurrent Intraocular Melanoma
Similarity Score18%

Elaine McWhirter

Princess Margaret Hospital Phase 2 Consortium

Related
1 trials

Shared therapeutic areas:

Ciliary Body and Choroid Melanoma, Medium/Large SizeExtraocular Extension MelanomaIris Melanoma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score18%

Matuesz Opyrchal, MD

Roswell Park Cancer Institute

Related
1 trials

Shared therapeutic areas:

Extraocular Extension MelanomaMetastatic Intraocular MelanomaRecurrent Intraocular Melanoma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score18%

Takami Sato, MD

Thomas Jefferson University

Related
2 trials

Shared therapeutic areas:

Ciliary Body and Choroid Melanoma, Medium/Large SizeIris Melanoma
Similarity Score12%

Francesco M. Marincola

National Cancer Institute (NCI)

Related
2 trials

Shared therapeutic areas:

Extraocular Extension MelanomaRecurrent Intraocular Melanoma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score12%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT00329641Phase 2PrincipalInvestigator

Sorafenib, Carboplatin, and Paclitaxel in Treating Patients With Stage IV Melanoma of the Eye

Ciliary Body and Choroid Melanoma, Medium/Large SizeExtraocular Extension MelanomaIris Melanoma+2 more
Completed

All 1 trials loaded